- Home
- AXTA vs HALO Comparison
AXTA vs HALO Comparison
Compare AXTA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXTA
- HALO
- Stock Information
- Founded
- AXTA 1910
- HALO 1998
- Country
- AXTA United States
- HALO United States
- Employees
- AXTA N/A
- HALO N/A
- Industry
- AXTA Paints/Coatings
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXTA Consumer Discretionary
- HALO Health Care
- Exchange
- AXTA Nasdaq
- HALO Nasdaq
- Market Cap
- AXTA 6.7B
- HALO 7.6B
- IPO Year
- AXTA 2014
- HALO N/A
- Fundamental
- Price
- AXTA $30.42
- HALO $67.27
- Analyst Decision
- AXTA Buy
- HALO Buy
- Analyst Count
- AXTA 14
- HALO 8
- Target Price
- AXTA $39.00
- HALO $69.63
- AVG Volume (30 Days)
- AXTA 3.1M
- HALO 1.8M
- Earning Date
- AXTA 07-30-2025
- HALO 08-05-2025
- Dividend Yield
- AXTA N/A
- HALO N/A
- EPS Growth
- AXTA 51.22
- HALO 68.93
- EPS
- AXTA 2.04
- HALO 4.37
- Revenue
- AXTA $5,198,000,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- AXTA $2.10
- HALO $25.38
- Revenue Next Year
- AXTA $3.30
- HALO $20.19
- P/E Ratio
- AXTA $15.00
- HALO $15.42
- Revenue Growth
- AXTA N/A
- HALO 34.97
- 52 Week Low
- AXTA $27.58
- HALO $42.01
- 52 Week High
- AXTA $41.66
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- AXTA 59.61
- HALO 80.45
- Support Level
- AXTA $28.17
- HALO $61.27
- Resistance Level
- AXTA $30.94
- HALO $65.40
- Average True Range (ATR)
- AXTA 0.71
- HALO 1.70
- MACD
- AXTA 0.29
- HALO 0.55
- Stochastic Oscillator
- AXTA 84.52
- HALO 98.71
About AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.